Trials / Completed
CompletedNCT00639249
Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke
A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Phase IIa Study of Safety and Motor Function Restoration in Subjects Treated With SA4503 Following Acute Ischemic Stroke
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- M's Science Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of SA4503 in patients recovering from a recent stroke. Secondary, to evaluate the efficacy of SA4503 compared to placebo.
Detailed description
Further study details as provided by M's Science Corporation:
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | Oral administration |
| DRUG | SA4503 Low | Oral administration |
| DRUG | SA4503 High | Oral administration |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-06-01
- First posted
- 2008-03-20
- Last updated
- 2009-07-29
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00639249. Inclusion in this directory is not an endorsement.